Does TOFACITINIB Cause Chronic obstructive pulmonary disease? 436 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 436 reports of Chronic obstructive pulmonary disease have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.3% of all adverse event reports for TOFACITINIB.
436
Reports of Chronic obstructive pulmonary disease with TOFACITINIB
0.3%
of all TOFACITINIB reports
24
Deaths
202
Hospitalizations
How Dangerous Is Chronic obstructive pulmonary disease From TOFACITINIB?
Of the 436 reports, 24 (5.5%) resulted in death, 202 (46.3%) required hospitalization, and 4 (0.9%) were considered life-threatening.
Is Chronic obstructive pulmonary disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 436 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Chronic obstructive pulmonary disease?
ALBUTEROL (2,916)
TIOTROPIUM (2,895)
BUDESONIDE\FORMOTEROL (2,279)
FLUTICASONE\SALMETEROL (1,904)
ADALIMUMAB (1,712)
PREDNISONE (1,237)
FLUTICASONE FUROATE\UMECLIDINIUM\VILANTEROL TRIFENATATE (1,145)
MEPOLIZUMAB (1,107)
FLUTICASONE FUROATE\VILANTEROL TRIFENATATE (967)
DUPILUMAB (907)
Which TOFACITINIB Alternatives Have Lower Chronic obstructive pulmonary disease Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN